Newer Treatments are Keeping Heart Failure Patients Healthier, Longer

The use of pacemakers, defibrillators and beta blockers earlier in heart failure patients are making.

While the number of patients with heart failure (HF) in the U.S. continues to rise, there is some encouraging news on this front. HF-related mortality and hospitalization rates are stabilizing. Improvements in medication and device therapies are helping to make HF a more manageable condition, according to a statement released by the American Heart Association (AHA) in February. The AHA noted that the quality of life for HF patients in general has also improved. Eileen Hsich, MD, director of the Womens Heart Failure Clinic at Cleveland Clinic, has done considerable research in this area, and agrees that many of these vulnerable patients are living longer and better lives because of how and when they are being treated.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access